Sanguinarine Inhibits Cell Growth in EBV-Positive Diffuse Large B-Cell Lymphoma

Lu, Suli; Yang, Dae-jung

doi:10.2478/aite-2025-0009

Abstract

To investigate the effects of Sanguinarine (SAG) on the progression of diffuse large B-cell lymphoma (DLBCL) and to explore its underlying mechanism, this study utilized Epstein–Barr virus (EBV)-positive DLBCL cell lines, FARAGE, and GM12878S. Cell counting kit-8 and bromodeoxyuridine assays were used to assess the effects of SAG on the cell proliferation. Flow cytometry and immunoblotting were employed to analyze cell cycle arrest and apoptosis. Additionally, the molecular mechanism was explored through further immunoblotting analysis of the mechanism. SAG suppressed the growth of EBV-positive DLBCL cells. Furthermore, SAG induced cell cycle arrest and promoted apoptosis in these cells. Mechanistically, SAG suppressed the Wnt/β-catenin pathway, thereby suppressing DLBCL progression in vitro. SAG effectively inhibits cell growth and induces apoptosis in EBV-positive DLBCL via Wnt/β-catenin pathway, offering potential therapeutic insights for this lymphoma subtype.

References

Alakkal A, Thayyullathil F, Pallichankandy S et al. (2022) Sanguinarine induces h(2)o(2)-dependent apoptosis and ferroptosis in human cervical cancer. Biomedicines 10:1795. https://doi.org/10.3390/biomedicines10081795
Search in Google Scholar Back to article
Dai R, Wu M, Zhang Y et al. (2021) G protein nucleolar 3 promotes non-Hodgkin lymphoma progression by activating the Wnt/beta-catenin signaling pathway. Exp Cell Res 409:112911. https://doi.org/10.1016/j.yexcr.2021.112911
Search in Google Scholar Back to article
De Souza LM, Ismail M, Elaskandrany MA et al. (2024) Primary hepatic EBV-DLBCL lymphoma in the setting of COVID-19 infection. ACG Case Rep J 11:e01276. https://doi.org/10.14309/crj.0000000000001276
Search in Google Scholar Back to article
Du X, Zhang M, Wang S et al. (2024) Ethnopharmacology, chemical composition and functions of Cymbopogon citratus. Chin Herb Med 16:358–374. https://doi.org/10.1016/j.chmed.2023.07.002
Search in Google Scholar Back to article
Huang LJ, Lan JX, Wang JH et al. (2024) Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years. Biomed Pharmacother 173:116406. https://doi.org/10.1016/j.biopha.2024.116406
Search in Google Scholar Back to article
Hu M, Trevino J, Yang L et al. (2018) Primary gastric EBV-positive diffuse large B cell lymphoma (DLBCL) of the elderly with plasmablastic differentiation. In Vivo 32:413–417. https://doi.org/10.21873/invivo.11255
Search in Google Scholar Back to article
Liu P, Zhao M, Lin Y et al. (2023) Platycodin D induces proliferation inhibition and mitochondrial apoptosis in diffuse large B-cell lymphoma. Exp Hematol 123:46–55. https://doi.org/10.1016/j.exphem.2023.04.002
Search in Google Scholar Back to article
Lu K, Li B, Zhang H et al. (2020) A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway. Signal Transduct Target Ther 5:31. https://doi.org/10.1038/s41392-020-0123-0
Search in Google Scholar Back to article
Narita K, Takeuchi K (2023) FISH for EBV genome in a patient with diffuse large B-cell lymphoma harboring t(14;18)(q32;q21). Blood 142:1172. https://doi.org/10.1182/blood.2023021546
Search in Google Scholar Back to article
Ohashi A, Kato S, Okamoto A et al. (2017) Reappraisal of Epstein–Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells. Histopathology 71:89–97. https://doi.org/10.1111/his.13197
Search in Google Scholar Back to article
Pallichankandy S, Thayyullathil F, Cheratta AR et al. (2023) Targeting oxeiptosis-mediated tumor suppression: a novel approach to treat colorectal cancers by sanguinarine. Cell Death Discov 9:94. https://doi.org/10.1038/s41420-023-01376-3
Search in Google Scholar Back to article
Prabhu KS, Bhat AA, Siveen KS et al. (2021) Sanguinarine mediated apoptosis in non-small cell lung cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway. Biomed Pharmacother 144:112358. https://doi.org/10.1016/j.biopha.2021.112358
Search in Google Scholar Back to article
Qi X, Chen Y, Liu S et al. (2023) Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway. Pharm Biol 61:696–709. https://doi.org/10.1080/13880209.2023.2200787
Search in Google Scholar Back to article
Qin TT, Li ZH, Li LX et al. (2022) Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration. Iran J Basic Med Sci 25:781–788. https://doi.org/10.22038/IJBMS.2022.62541.13851
Search in Google Scholar Back to article
Ren K, Pei J, Guo Y et al. (2023) Regulated necrosis pathways: a potential target for ischemic stroke. Burns Trauma 11:tkad016. https://doi.org/10.1093/burnst/tkad016
Search in Google Scholar Back to article
Seog W, Tae K, Kim M, Cho S-G et al. (2025) Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial.[J]. Nat Cancer. Doi: 10.1038/s43018-025-00921-6
Open DOI Search in Google Scholar Back to article
Shold J, Jukic L, Farrell D et al. (2024) EBV positive diffuse large B cell lymphoma with negative Pan-B cell markers, case report, and literature review. Case Rep Hematol 2024:4803071. https://doi.org/10.1155/2024/4803071
Search in Google Scholar Back to article
Tang D, Su W, Wang X et al. (2021) Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas. Brain Tumor Pathol 38:50–58. https://doi.org/10.1007/s10014-020-00386-8
Search in Google Scholar Back to article
Xing X, Liu M, Wang X et al. (2023) FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.[J]. J Cell Mol Med 28(1):e18041.
Search in Google Scholar Back to article
Xing X, Liu M, Wang X et al. (2024) FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/beta-catenin signalling. J Cell Mol Med 28:e18041. https://doi.org/10.1111/jcmm.18041
Search in Google Scholar Back to article
Yang Y, Liu D, Wang Y (2023) Physalin A exerts neuroprotective effects: inhibition of OGD/R-induced cellular pyroptosis and inflammatory responses in nerve cells. Signa Vitae 19:168–174. https://doi.org/10.22514/sv.2023.111
Search in Google Scholar Back to article
Zhan Y, Teruya-Feldstein J (2019) Immune dysregulation: EBV(+) DLBCL and HLH in a patient with T-LGL. Blood 133:1695. https://doi.org/10.1182/blood-2019-01-899484
Search in Google Scholar Back to article
Zhang Q, Lai J, Ai S et al. (2024) A case report of surgery-radiotherapy-chemotherapy cured primary diffuse large B-cell lymphoma of the central nervous system associated with HIV infection.[J]. Diagn Pathol 19(1):153.
Search in Google Scholar Back to article

Sanguinarine Inhibits Cell Growth in EBV-Positive Diffuse Large B-Cell Lymphoma

Abstract

Paradigm

My account